244 related articles for article (PubMed ID: 29264364)
1. Defects in innate and adaptive immunity in patients with sepsis and health care associated infection.
Ryan T; Coakley JD; Martin-Loeches I
Ann Transl Med; 2017 Nov; 5(22):447. PubMed ID: 29264364
[TBL] [Abstract][Full Text] [Related]
2. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
3. Diabetes and Sepsis: Risk, Recurrence, and Ruination.
Frydrych LM; Fattahi F; He K; Ward PA; Delano MJ
Front Endocrinol (Lausanne); 2017; 8():271. PubMed ID: 29163354
[TBL] [Abstract][Full Text] [Related]
4. The immune system's role in sepsis progression, resolution, and long-term outcome.
Delano MJ; Ward PA
Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis.
Nedeva C
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356636
[TBL] [Abstract][Full Text] [Related]
6. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
Front Immunol; 2022; 13():891024. PubMed ID: 35619710
[TBL] [Abstract][Full Text] [Related]
7. Innate Lymphocyte Th1 and Th17 Responses in Elderly Hospitalised Patients with Infection and Sepsis.
Coakley JD; Breen EP; Moreno-Olivera A; Al-Harbi AI; Melo AM; O'Connell B; McManus R; Doherty DG; Ryan T
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32560376
[No Abstract] [Full Text] [Related]
8. Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients.
Kompoti M; Michopoulos A; Michalia M; Clouva-Molyvdas PM; Germenis AE; Speletas M
Immunobiology; 2015 Mar; 220(3):414-21. PubMed ID: 25454804
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary defense mechanisms against pneumonia and sepsis.
Tsai KS; Grayson MH
Curr Opin Pulm Med; 2008 May; 14(3):260-5. PubMed ID: 18427251
[TBL] [Abstract][Full Text] [Related]
11. Management of severe sepsis and septic shock.
Sessler CN; Perry JC; Varney KL
Curr Opin Crit Care; 2004 Oct; 10(5):354-63. PubMed ID: 15385751
[TBL] [Abstract][Full Text] [Related]
12. [The latest research advance in media involved in sepsis].
Hao Y; Geng L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):188-92. PubMed ID: 26911956
[TBL] [Abstract][Full Text] [Related]
13. A new paradigm for the treatment of sepsis: is it time to consider combination therapy?
Cross AS; Opal SM
Ann Intern Med; 2003 Mar; 138(6):502-5. PubMed ID: 12639085
[TBL] [Abstract][Full Text] [Related]
14. Role of cellular events in the pathophysiology of sepsis.
Bhan C; Dipankar P; Chakraborty P; Sarangi PP
Inflamm Res; 2016 Nov; 65(11):853-868. PubMed ID: 27392441
[TBL] [Abstract][Full Text] [Related]
15. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.
Horiguchi H; Loftus TJ; Hawkins RB; Raymond SL; Stortz JA; Hollen MK; Weiss BP; Miller ES; Bihorac A; Larson SD; Mohr AM; Brakenridge SC; Tsujimoto H; Ueno H; Moore FA; Moldawer LL; Efron PA;
Front Immunol; 2018; 9():595. PubMed ID: 29670613
[TBL] [Abstract][Full Text] [Related]
16. Goodbye SIRS? Innate, trained and adaptive immunity and pathogenesis of organ dysfunction.
Ghnewa YG; Fish M; Jennings A; Carter MJ; Shankar-Hari M
Med Klin Intensivmed Notfmed; 2020 May; 115(Suppl 1):10-14. PubMed ID: 32291506
[TBL] [Abstract][Full Text] [Related]
17. Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches.
Raymond SL; Stortz JA; Mira JC; Larson SD; Wynn JL; Moldawer LL
Front Pediatr; 2017; 5():14. PubMed ID: 28224121
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
Patil NK; Bohannon JK; Sherwood ER
Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study.
Baykara N; Akalın H; Arslantaş MK; Hancı V; Çağlayan Ç; Kahveci F; Demirağ K; Baydemir C; Ünal N;
Crit Care; 2018 Apr; 22(1):93. PubMed ID: 29656714
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells in sepsis: Underprivileged innate immune cells.
Kumar V
Eur J Cell Biol; 2019 Jun; 98(2-4):81-93. PubMed ID: 30583806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
